Female genital mutilation status
ICD-10 N90.81 is a billable code used to indicate a diagnosis of female genital mutilation status.
Female genital mutilation (FGM) status refers to the condition of individuals who have undergone FGM, which is a practice involving the partial or total removal of the external female genitalia for non-medical reasons. This practice is recognized as a violation of human rights and can lead to various health complications, including psychological trauma, chronic pain, and complications during childbirth. The ICD-10 code N90.81 is used to document the status of individuals who have experienced FGM, which is crucial for providing appropriate medical care and support. It is important for healthcare providers to be aware of the potential long-term effects of FGM, including increased risk of obstetric complications, urinary tract infections, and sexual dysfunction. Accurate coding of FGM status is essential for tracking health outcomes and ensuring that affected individuals receive comprehensive care tailored to their unique needs. This code is particularly relevant in obstetrics and gynecology, where understanding a patient's history of FGM can inform treatment decisions and management strategies.
Detailed patient history regarding FGM, including type and extent of mutilation, and any related complications.
Management of pregnancy in women with a history of FGM, addressing complications during labor.
Sensitivity in discussing FGM with patients and understanding cultural implications.
Assessment of psychological impact and trauma related to FGM.
Treatment of PTSD or anxiety disorders in patients with a history of FGM.
Cultural competence in addressing the mental health needs of affected individuals.
Used for patients with a history of FGM requiring comprehensive obstetric care.
Document FGM status and any related complications in the medical record.
Obstetricians should be aware of the implications of FGM on labor and delivery.
Coding N90.81 is crucial for identifying patients who have undergone FGM, which can inform treatment plans and improve health outcomes. It also helps in tracking the prevalence of FGM and advocating for better healthcare policies.
